Endobronchial brachytherapy may be considered medically necessary in the following clinical situations:
In individuals with primary endobronchial tumors who are not otherwise candidates for surgical resection or external-beam radiotherapy due to comorbidities or location of the tumor.
As a palliative therapy for airway obstruction or severe hemoptysis in individuals with primary, metastatic, or recurrent endobronchial tumors.
Other applications of endobronchial brachytherapy are investigational including, but not limited to, its use as a radiation «boost» to curative external-beam radiotherapy, as a treatment for asymptomatic recurrences of non-small cell lung cancer, or in the treatment of hyperplastic granulation tissue.
